Discussion Here, we reported a brand-new dual regulatory mechanism acting on a mitochondrial transporter protein, by both protein quality control and metabolic sensing, which directly controls mitochondrial glutathione level in response to iron homeostasis (Fig
607 The iron uptake inhibitor ferristatin II provides neuroprotection by suppressing ferroptosis, and HBED treatment alleviates secondary damage after TBI by binding to Fe 2+ and converting Fe 2+ to Fe 3+
Topical GHK-Cu has been studied in controlled human trials for wrinkle reduction, collagen synthesis, and post-procedure healing
Author contributions JC: Validation, Methodology, Investigation, Visualization, Data curation, Formal analysis, Conceptualization, Writing review & editing, Writing original draft, Project administration